Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

496
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
496
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

196
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
196
Dementia01:30

Dementia

117
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
117

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revolutionizing Transcriptomics: From Single-Cell Insights to RNA-based Interventions.

SLAS technology·2026
Same author

A robust direction of arrival estimation method based on the chaotic MUSIC algorithm.

Scientific reports·2026
Same author

Electrically Reconfigurable Floating Gate Optoelectronic Synaptic Pixels for In-sensor Convolutional Image Feature Extraction with Built-in Contrast Enhancement.

ACS nano·2026
Same author

Precision Biomarker Identification in Gynecological Cancers Using Coexpression Networks and Attention-Based LSTM in Healthcare 4.0.

Diagnostics (Basel, Switzerland)·2026
Same author

Impact of Contact Gating on Scaling of Monolayer 2D Transistors Using a Symmetric Dual-Gate Structure.

ACS nano·2026
Same author

Multimodal fusion and explainability of artificial intelligence models in Alzheimer's Disease detection.

Brain informatics·2026

Related Experiment Video

Updated: Jul 11, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K

Explainable AI-based Alzheimer's prediction and management using multimodal data.

Sobhana Jahan1,2, Kazi Abu Taher2, M Shamim Kaiser3

  • 1Department of Computer Science and Engineering, Bangladesh University of Professionals, Dhaka, Bangladesh.

Plos One
|November 16, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces an explainable machine learning model for Alzheimer's disease diagnosis using multimodal data. The Random Forest model achieved 98.81% accuracy, improving trust and performance in Alzheimer's prediction.

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

Related Experiment Videos

Last Updated: Jul 11, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

Area of Science:

  • Neuroscience
  • Artificial Intelligence
  • Medical Informatics

Background:

  • Dementia, including Alzheimer's disease, is a leading cause of death and disability globally.
  • Current machine learning models for Alzheimer's diagnosis lack trust due to their black-box nature and often rely solely on neuroimaging data.
  • There is a need for improved, explainable diagnostic tools for Alzheimer's disease.

Purpose of the Study:

  • To propose a novel, explainable Alzheimer's disease prediction model using a multimodal dataset.
  • To address the limitations of existing models by incorporating clinical, MRI segmentation, and psychological data.
  • To advance the understanding of multimodal five-class classification for Alzheimer's disease.

Main Methods:

  • Utilized nine popular machine learning models, including Random Forest (RF), Logistic Regression (LR), and Support Vector Machine (SVM), for five-class classification.
  • Performed data-level fusion of clinical, MRI segmentation, and psychological data.
  • Employed SHapley Additive exPlanation (SHAP) for model explainability.

Main Results:

  • The Random Forest classifier achieved a 10-fold cross-validation accuracy of 98.81% for classifying Alzheimer's disease, cognitively normal, non-Alzheimer's dementia, uncertain dementia, and others.
  • Explainable AI (XAI) using SHAP provided insights into the prediction reasoning.
  • The study is the first to present a multimodal five-class classification of Alzheimer's disease using the OASIS-3 dataset.

Conclusions:

  • The developed explainable AI model demonstrates high accuracy and reliability in Alzheimer's disease prediction.
  • Multimodal data fusion significantly enhances diagnostic capabilities for Alzheimer's disease.
  • A novel Alzheimer's patient management architecture was proposed, offering potential for improved patient care.